These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12570659)

  • 1. Oncogenic signaling pathways activated by RON receptor tyrosine kinase.
    Danilkovitch-Miagkova A
    Curr Cancer Drug Targets; 2003 Feb; 3(1):31-40. PubMed ID: 12570659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinases involved in MSP/RON signaling.
    Danilkovitch A; Leonard EJ
    J Leukoc Biol; 1999 Mar; 65(3):345-8. PubMed ID: 10080538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors.
    Danilkovitch-Miagkova A; Leonard EJ
    Histol Histopathol; 2001 Apr; 16(2):623-31. PubMed ID: 11332718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
    Feres KJ; Ischenko I; Hayman MJ
    Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.
    Lu T; Wang Z; Prativa S; Xu Y; Wang T; Zhang Y; Yu L; Xu N; Tang J; You W; Chen G; Zhang JH
    J Neurochem; 2019 Jan; 148(1):114-126. PubMed ID: 30380151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.
    Chao KL; Gorlatova NV; Eisenstein E; Herzberg O
    J Biol Chem; 2014 Oct; 289(43):29948-60. PubMed ID: 25193665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
    Peace BE; Hughes MJ; Degen SJ; Waltz SE
    Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein.
    Wang MH; Montero-Julian FA; Dauny I; Leonard EJ
    Oncogene; 1996 Nov; 13(10):2167-75. PubMed ID: 8950984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
    Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
    Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein.
    Ray M; Yu S; Sharda DR; Wilson CB; Liu Q; Kaushal N; Prabhu KS; Hankey PA
    J Immunol; 2010 Dec; 185(12):7309-16. PubMed ID: 21078906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.
    Santoro MM; Penengo L; Minetto M; Orecchia S; Cilli M; Gaudino G
    Oncogene; 1998 Aug; 17(6):741-9. PubMed ID: 9715276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.
    Millar R; Kilbey A; Remak SJ; Severson TM; Dhayade S; Sandilands E; Foster K; Bryant DM; Blyth K; Coffelt SB
    Mol Oncol; 2020 Aug; 14(8):1868-1880. PubMed ID: 32484599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
    Morrison AC; Wilson CB; Ray M; Correll PH
    J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.
    Kauder SE; Santell L; Mai E; Wright LY; Luis E; N'Diaye EN; Lutman J; Ratti N; Sa SM; Maun HR; Stefanich E; Gonzalez LC; Graham RR; Diehl L; Faubion WA; Keir ME; Young J; Chaudhuri A; Lazarus RA; Egen JG
    PLoS One; 2013; 8(12):e83958. PubMed ID: 24409221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ron-receptor tyrosine kinase in tumorigenesis and metastasis.
    Leonis MA; Thobe MN; Waltz SE
    Future Oncol; 2007 Aug; 3(4):441-8. PubMed ID: 17661719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.
    Kretschmann KL; Eyob H; Buys SS; Welm AL
    Curr Drug Targets; 2010 Sep; 11(9):1157-68. PubMed ID: 20545605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.
    Huang L; Fang X; Shi D; Yao S; Wu W; Fang Q; Yao H
    Front Immunol; 2020; 11():569082. PubMed ID: 33117355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.